1-8 of 8
Aafke E. Gaartman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Artificial-Intelligence Driven Quantification of Sickle Red Blood Cell Morphology As an Objective Disease Marker

Lydian A. De Ligt, Eelke Brandsma, Aafke E. Gaartman, Guusje Van Gameren, Colin Blans, Martijn Veldthuis, Hanke Matlung, Bart J. Biemond, Erfan Nur, Emile Van Den Akker, Robin van Bruggen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4996.
https://doi.org/10.1182/blood-2024-199994
Published: 2024
Journal Articles

Plasma Proteome Profiling of Sickle Cell Patients Reveals Activation of Inflammatory Pathways during Steady State and Vaso-Occlusive Crisis

Lydian A. de Ligt, Aafke E. Gaartman, Kadère Konté, Taco W. Kuijpers, Karin Fijnvandraat, Bart J. Biemond, Robin van Bruggen, Erfan Nur
Journal: Blood
Blood (2023) 142 (Supplement 1): 1108.
https://doi.org/10.1182/blood-2023-179239
Published: 2023
Journal Articles

The Effect of Voxelotor on Erythrocyte Deformability, Neutrophil Phenotype and Endothelial Activation

Kadère Konté, Aafke E. Gaartman, Isha Tanwar, Boukje Beuger, Martijn Veldthuis, Rob Van Zwieten, Robin van Bruggen, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2023) 142 (Supplement 1): 3872.
https://doi.org/10.1182/blood-2023-185822
Published: 2023
Journal Articles

Pleiotropic Effects of Hydroxyurea on Red Blood Cell and Neutrophil Phenotype in Patients with Sickle Cell Disease; Data from the Notice Study

Aafke E. Gaartman, Lydian A. de Ligt, Anton T.J. Tool, Boukje M. Beuger, Martijn Veldthuis, Taco W. Kuijpers, Rob van Zwieten, Bart J. Biemond, Robin Van Bruggen, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 2551–2553.
https://doi.org/10.1182/blood-2022-169070
Published: 2022
Journal Articles

Voxelotor Treatment Leads to Improved Viability of Sickle Erythrocytes and Altered Neutrophil Phenotype

Kadère Konté, Aafke E. Gaartman, Boukje M. Beuger, Martijn Veldthuis, Rob van Zwieten, Robin Van Bruggen, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 11114–11115.
https://doi.org/10.1182/blood-2022-170527
Published: 2022
Journal Articles

Complications of Extra Fluid Therapy (Hyperhydration) in Sickle Cell Patients during Vaso-Occlusive Painful Crisis

Aafke E. Gaartman, MD, Ajab K. Sayedi, BSc, Charlotte F.J. Van Tuijn, MPH, PhD, Harriet Heijboer, MD PhD, Tanja Netelenbos, MD PhD, Bart J. Biemond, MD PhD, Erfan Nur, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1024.
https://doi.org/10.1182/blood-2019-130248
Published: 2019
Journal Articles

Adding Azathioprine and Hydroxyurea Preconditioning to Alemtuzumab/TBI May Improve Donor Chimerism in Matched Sibling Donor Allogeneic Stem Cell Transplantation in Adult Sickle Cell Patients

Erfan Nur, MD PhD, Sacha S Zeerleder, MD PhD, Aafke E. Gaartman, MD, Caroline E Rutten, MD PhD, Charlotte F.J. Van Tuijn, MPH, PhD, Liesbeth E.M. Suijk, Mette D Hazenberg, MD PhD, Bart J. Biemond, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 997.
https://doi.org/10.1182/blood-2019-129403
Published: 2019
Journal Articles

Incentive Spirometry to Prevent Acute Chest Syndrome in Adults with Sickle Cell Disease

Bart J. Biemond, MD PhD, Charlotte F.J. Van Tuijn, MPH, PhD, Aafke E. Gaartman, MD, Erfan Nur, MD PhD, A. W. Rijneveld, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3660.
https://doi.org/10.1182/blood-2018-99-117450
Published: 2018